Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Obesity Prevalence on the Rise in Early RA

Rheumatology (Oxford); ePub 2018 Mar 26; Nikiphorou, et al

Obesity prevalence is rising in early rheumatoid arthritis (RA) and associates with worse disease activity, function, and health-related quality of life, with a significant negative impact on achieving a low Disease Activity Score (DAS28), a recent study found. Data from 2 consecutive, similarly designed multicenter RA inception cohorts were used: Early RA Study (ERAS) and Early RA Network (ERAN). Recruitment figures/median follow-up for the ERAS and ERAN were 1,465/10 years (maximum 25 years), and 1,236/6 years (maximum 10 years), respectively. Multilevel piecewise longitudinal models with a change point at 2 years were used with the DAS28, erythrocyte sedimentation rate (ESR), Health Assessment Questionnaire (HAQ), and 36-item Short Form Health Survey (SF-36) physical (PCS) and mental (MCS) components as dependent variables. Researchers found:

  • BMI data from 2,386 newly diagnosed RA patients (11,348 measures) showed an increase in BMI of 0.27 U annually.
  • Baseline obesity was associated with a significant reduction in the odds of achieving a low year 2 DAS28.
  • At year 2, HAQ and SF-36 PCS scores were significantly worse but not at year 5 in patients obese at baseline.
Citation:

Nikiphorou E, Norton S, Young A, et al. The association of obesity with disease activity, functional ability and quality of life in early rheumatoid arthritis: Data from the Early Rheumatoid Arthritis Study/Early Rheumatoid Arthritis Network UK prospective cohorts. [Published online ahead of print March 26, 2018]. Rheumatology (Oxford). doi:10.1093/rheumatology/key066.